Regina A.R.A.ShihRegina A.R.A., Pamela L.P.L.BelmontePamela L.P.L., Peter P.P.P.ZandiPeter P.P.P., A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders, „International Review of Psychiatry (Abingdon, England)”, 16 (4), 2004, s. 260–283, DOI: 10.1080/09540260400014401, ISSN0954-0261, PMID: 16194760.
M.J.M.J.OwenM.J.M.J., N.N.CraddockN.N., M.C.M.C.O'DonovanM.C.M.C., Schizophrenia: genes at last?, „Trends in genetics: TIG”, 21 (9), 2005, s. 518–525, DOI: 10.1016/j.tig.2005.06.011, ISSN0168-9525, PMID: 16009449.
Michael C.M.C.O'DonovanMichael C.M.C., Nigel M.N.M.WilliamsNigel M.N.M., Michael J.M.J.OwenMichael J.M.J., Recent advances in the genetics of schizophrenia, „Human Molecular Genetics”, 12 Spec No 2, 2003, R125–133, DOI: 10.1093/hmg/ddg302, ISSN0964-6906, PMID: 12952866.
NickN.CraddockNickN., Michael C.M.C.O'DonovanMichael C.M.C., Michael J.M.J.OwenMichael J.M.J., Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology, „Schizophrenia Bulletin”, 32 (1), 2006, s. 9–16, DOI: 10.1093/schbul/sbj033, ISSN0586-7614, PMID: 16319375, PMCID: PMC2632175.
Jean-PaulJ.P.SeltenJean-PaulJ.P., ElizabethE.Cantor-GraaeElizabethE., René S.R.S.KahnRené S.R.S., Migration and schizophrenia, „Current Opinion in Psychiatry”, 20 (2), 2007, s. 111–115, DOI: 10.1097/YCO.0b013e328017f68e, ISSN0951-7367, PMID: 17278906.
Lindsay S.L.S.SchenkelLindsay S.L.S. i inni, Histories of childhood maltreatment in schizophrenia: relationships with premorbid functioning, symptomatology, and cognitive deficits, „Schizophrenia Research”, 76 (2-3), 2005, s. 273–286, DOI: 10.1016/j.schres.2005.03.003, ISSN0920-9964, PMID: 15949659.
Richard P.R.P.BentallRichard P.R.P. i inni, Prospects for a cognitive-developmental account of psychotic experiences, „The British Journal of Clinical Psychology”, 46 (Pt 2), 2007, s. 155–173, DOI: 10.1348/014466506X123011, ISSN0144-6657, PMID: 17524210.
H.-L.H.L.WangH.-L.H.L. i inni, Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia, „Acta Psychiatrica Scandinavica”, 114 (1), 2006, s. 40–48, DOI: 10.1111/j.1600-0447.2006.00780.x, ISSN0001-690X, PMID: 16774660.
LynseyL.GreggLynseyL., ChristineCh.BarrowcloughChristineCh., GillianG.HaddockGillianG., Reasons for increased substance use in psychosis, „Clinical Psychology Review”, 27 (4), 2007, s. 494–510, DOI: 10.1016/j.cpr.2006.09.004, ISSN0272-7358, PMID: 17240501.
LouiseL.ArseneaultLouiseL. i inni, Causal association between cannabis and psychosis: examination of the evidence, „The British Journal of Psychiatry: The Journal of Mental Science”, 184, 2004, s. 110–117, DOI: 10.1192/bjp.184.2.110, ISSN0007-1250, PMID: 14754822.
MartinM.BrüneMartinM. i inni, Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best?, „Schizophrenia Research”, 92 (1-3), 2007, s. 151–159, DOI: 10.1016/j.schres.2007.01.006, ISSN0920-9964, PMID: 17346931.
Margriet M.M.M.SitskoornMargriet M.M.M. i inni, Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis, „Schizophrenia Research”, 71 (2-3), 2004, s. 285–295, DOI: 10.1016/j.schres.2004.03.007, ISSN0920-9964, PMID: 15474899.
Matthew M.M.M.KurtzMatthew M.M.M., Neurocognitive impairment across the lifespan in schizophrenia: an update, „Schizophrenia Research”, 74 (1), 2005, s. 15–26, DOI: 10.1016/j.schres.2004.07.005, ISSN0920-9964, PMID: 15694750.
Alex S.A.S.CohenAlex S.A.S., Nancy M.N.M.DochertyNancy M.N.M., Affective reactivity of speech and emotional experience in patients with schizophrenia, „Schizophrenia Research”, 69 (1), 2004, s. 7–14, DOI: 10.1016/S0920-9964(03)00069-0, ISSN0920-9964, PMID: 15145465.
ChristineCh.BarrowcloughChristineCh. i inni, Self-esteem in schizophrenia: relationships between self-evaluation, family attitudes, and symptomatology, „Journal of Abnormal Psychology”, 112 (1), 2003, s. 92–99, DOI: 10.1037/0021-843X.112.1.92, ISSN0021-843X, PMID: 12653417.
BenB.SmithBenB. i inni, Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations, „Schizophrenia Research”, 86 (1-3), 2006, s. 181–188, DOI: 10.1016/j.schres.2006.06.018, ISSN0920-9964, PMID: 16857346.
Aaron T.A.T.BeckAaron T.A.T., A Cognitive Model of Schizophrenia, „Journal of Cognitive Psychotherapy”, 18 (3), 2004, s. 281–288, DOI: 10.1891/jcop.18.3.281.65649.
VaughanV.BellVaughanV., Peter W.P.W.HalliganPeter W.P.W., Hadyn D.H.D.EllisHadyn D.H.D., Explaining delusions: a cognitive perspective, „Trends in Cognitive Sciences”, 10 (5), 2006, s. 219–226, DOI: 10.1016/j.tics.2006.03.004, ISSN1364-6613, PMID: 16600666.
ElizabethE.KuipersElizabethE. i inni, Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms, „Schizophrenia Bulletin”, 32 Suppl 1, 2006, S24–31, DOI: 10.1093/schbul/sbl014, ISSN0586-7614, PMID: 16885206, PMCID: PMC2632539.
A.C.A.C.LahtiA.C.A.C. i inni, Effects of ketamine in normal and schizophrenic volunteers, „Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology”, 25 (4), 2001, s. 455–467, DOI: 10.1016/S0893-133X(01)00243-3, ISSN0893-133X, PMID: 11557159.
Harri J.H.J.TuominenHarri J.H.J., JariJ.TiihonenJariJ., KristianK.WahlbeckKristianK., Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis, „Schizophrenia Research”, 72 (2-3), 2005, s. 225–234, DOI: 10.1016/j.schres.2004.05.005, ISSN0920-9964, PMID: 15560967.1 stycznia
Laura A.L.A.FlashmanLaura A.L.A., Michael F.M.F.GreenMichael F.M.F., Review of cognition and brain structure in schizophrenia: profiles, longitudinal course, and effects of treatment, „The Psychiatric Clinics of North America”, 27 (1), 2004, s. 1–18, vii, DOI: 10.1016/S0193-953X(03)00105-9, ISSN0193-953X, PMID: 15062627.
Amanda L.A.L.JonesAmanda L.A.L. i inni, Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?, „Immunology and Cell Biology”, 83 (1), 2005, s. 9–17, DOI: 10.1111/j.1440-1711.2005.01305.x, ISSN0818-9641, PMID: 15661036.
Rael D.R.D.StrousRael D.R.D., YehudaY.ShoenfeldYehudaY., Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited, „Journal of Autoimmunity”, 27 (2), 2006, s. 71–80, DOI: 10.1016/j.jaut.2006.07.006, ISSN0896-8411, PMID: 16997531.
MeltzerM.HMeltzerM. i inni, OPCS Surveys of Psychiatric Morbidity Report 3: Economic Activity and Social Functioning of Adults With Psychiatric Disorders., London, Her Majesty’s Stationery Office, 1995. Brak numerów stron w książceAvailable for fee.
nih.gov
ncbi.nlm.nih.gov
AndreasA.Meyer-LindenbergAndreasA. i inni, Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia, „Nature Neuroscience”, 5 (3), 2002, s. 267–271, DOI: 10.1038/nn804, ISSN1097-6256, PMID: 11865311.
R.R.DayR.R. i inni, Stressful life events preceding the acute onset of schizophrenia: a cross-national study from the World Health Organization, „Culture, Medicine and Psychiatry”, 11 (2), 1987, s. 123–205, ISSN0165-005X, PMID: 3595169.a?
CherylCh.CorcoranCherylCh. i inni, The stress cascade and schizophrenia: etiology and onset, „Schizophrenia Bulletin”, 29 (4), 2003, s. 671–692, ISSN0586-7614, PMID: 14989406.
Regina A.R.A.ShihRegina A.R.A., Pamela L.P.L.BelmontePamela L.P.L., Peter P.P.P.ZandiPeter P.P.P., A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders, „International Review of Psychiatry (Abingdon, England)”, 16 (4), 2004, s. 260–283, DOI: 10.1080/09540260400014401, ISSN0954-0261, PMID: 16194760.
M.J.M.J.OwenM.J.M.J., N.N.CraddockN.N., M.C.M.C.O'DonovanM.C.M.C., Schizophrenia: genes at last?, „Trends in genetics: TIG”, 21 (9), 2005, s. 518–525, DOI: 10.1016/j.tig.2005.06.011, ISSN0168-9525, PMID: 16009449.
Michael C.M.C.O'DonovanMichael C.M.C., Nigel M.N.M.WilliamsNigel M.N.M., Michael J.M.J.OwenMichael J.M.J., Recent advances in the genetics of schizophrenia, „Human Molecular Genetics”, 12 Spec No 2, 2003, R125–133, DOI: 10.1093/hmg/ddg302, ISSN0964-6906, PMID: 12952866.
NickN.CraddockNickN., Michael C.M.C.O'DonovanMichael C.M.C., Michael J.M.J.OwenMichael J.M.J., Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology, „Schizophrenia Bulletin”, 32 (1), 2006, s. 9–16, DOI: 10.1093/schbul/sbj033, ISSN0586-7614, PMID: 16319375, PMCID: PMC2632175.
J.T.J.T.DalbyJ.T.J.T., D.D.MorganD.D., M.L.M.L.LeeM.L.M.L., Schizophrenia and mania in identical twin brothers, „The Journal of Nervous and Mental Disease”, 174 (5), 1986, s. 304–308, ISSN0022-3018, PMID: 3701318.
Jean-PaulJ.P.SeltenJean-PaulJ.P., ElizabethE.Cantor-GraaeElizabethE., René S.R.S.KahnRené S.R.S., Migration and schizophrenia, „Current Opinion in Psychiatry”, 20 (2), 2007, s. 111–115, DOI: 10.1097/YCO.0b013e328017f68e, ISSN0951-7367, PMID: 17278906.
Lindsay S.L.S.SchenkelLindsay S.L.S. i inni, Histories of childhood maltreatment in schizophrenia: relationships with premorbid functioning, symptomatology, and cognitive deficits, „Schizophrenia Research”, 76 (2-3), 2005, s. 273–286, DOI: 10.1016/j.schres.2005.03.003, ISSN0920-9964, PMID: 15949659.
I.I.JanssenI.I. i inni, Childhood abuse as a risk factor for psychotic experiences, „Acta Psychiatrica Scandinavica”, 109 (1), 2004, s. 38–45, ISSN0001-690X, PMID: 14674957.
Richard P.R.P.BentallRichard P.R.P. i inni, Prospects for a cognitive-developmental account of psychotic experiences, „The British Journal of Clinical Psychology”, 46 (Pt 2), 2007, s. 155–173, DOI: 10.1348/014466506X123011, ISSN0144-6657, PMID: 17524210.
Kenneth L.K.L.SubotnikKenneth L.K.L. i inni, Are communication deviance and expressed emotion related to family history of psychiatric disorders in schizophrenia?, „Schizophrenia Bulletin”, 28 (4), 2002, s. 719–729, ISSN0586-7614, PMID: 12795501.
H.-L.H.L.WangH.-L.H.L. i inni, Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia, „Acta Psychiatrica Scandinavica”, 114 (1), 2006, s. 40–48, DOI: 10.1111/j.1600-0447.2006.00780.x, ISSN0001-690X, PMID: 16774660.
LynseyL.GreggLynseyL., ChristineCh.BarrowcloughChristineCh., GillianG.HaddockGillianG., Reasons for increased substance use in psychosis, „Clinical Psychology Review”, 27 (4), 2007, s. 494–510, DOI: 10.1016/j.cpr.2006.09.004, ISSN0272-7358, PMID: 17240501.
K.T.K.T.MueserK.T.K.T. i inni, Prevalence of substance abuse in schizophrenia: demographic and clinical correlates, „Schizophrenia Bulletin”, 16 (1), 1990, s. 31–56, ISSN0586-7614, PMID: 2333480.
LouiseL.ArseneaultLouiseL. i inni, Causal association between cannabis and psychosis: examination of the evidence, „The British Journal of Psychiatry: The Journal of Mental Science”, 184, 2004, s. 110–117, DOI: 10.1192/bjp.184.2.110, ISSN0007-1250, PMID: 14754822.
S.S.AndréassonS.S. i inni, Cannabis and schizophrenia. A longitudinal study of Swedish conscripts, „The Lancet”, 2 (8574), London, England 1987, s. 1483–1486, ISSN0140-6736, PMID: 2892048.
RalphR.LewisRalphR., Should cognitive deficit be a diagnostic criterion for schizophrenia?, „Journal of psychiatry & neuroscience: JPN”, 29 (2), 2004, s. 102–113, ISSN1180-4882, PMID: 15069464.
MartinM.BrüneMartinM. i inni, Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best?, „Schizophrenia Research”, 92 (1-3), 2007, s. 151–159, DOI: 10.1016/j.schres.2007.01.006, ISSN0920-9964, PMID: 17346931.
Margriet M.M.M.SitskoornMargriet M.M.M. i inni, Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis, „Schizophrenia Research”, 71 (2-3), 2004, s. 285–295, DOI: 10.1016/j.schres.2004.03.007, ISSN0920-9964, PMID: 15474899.
Matthew M.M.M.KurtzMatthew M.M.M., Neurocognitive impairment across the lifespan in schizophrenia: an update, „Schizophrenia Research”, 74 (1), 2005, s. 15–26, DOI: 10.1016/j.schres.2004.07.005, ISSN0920-9964, PMID: 15694750.
Alex S.A.S.CohenAlex S.A.S., Nancy M.N.M.DochertyNancy M.N.M., Affective reactivity of speech and emotional experience in patients with schizophrenia, „Schizophrenia Research”, 69 (1), 2004, s. 7–14, DOI: 10.1016/S0920-9964(03)00069-0, ISSN0920-9964, PMID: 15145465.
William P.W.P.HoranWilliam P.W.P., Jack J.J.J.BlanchardJack J.J.J., Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping, „Schizophrenia Research”, 60 (2-3), 2003, s. 271–283, ISSN0920-9964, PMID: 12591589.
ChristineCh.BarrowcloughChristineCh. i inni, Self-esteem in schizophrenia: relationships between self-evaluation, family attitudes, and symptomatology, „Journal of Abnormal Psychology”, 112 (1), 2003, s. 92–99, DOI: 10.1037/0021-843X.112.1.92, ISSN0021-843X, PMID: 12653417.
M.M.BirchwoodM.M. i inni, The power and omnipotence of voices: subordination and entrapment by voices and significant others, „Psychological Medicine”, 30 (2), 2000, s. 337–344, ISSN0033-2917, PMID: 10824654.
BenB.SmithBenB. i inni, Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations, „Schizophrenia Research”, 86 (1-3), 2006, s. 181–188, DOI: 10.1016/j.schres.2006.06.018, ISSN0920-9964, PMID: 16857346.
VaughanV.BellVaughanV., Peter W.P.W.HalliganPeter W.P.W., Hadyn D.H.D.EllisHadyn D.H.D., Explaining delusions: a cognitive perspective, „Trends in Cognitive Sciences”, 10 (5), 2006, s. 219–226, DOI: 10.1016/j.tics.2006.03.004, ISSN1364-6613, PMID: 16600666.
ElizabethE.KuipersElizabethE. i inni, Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms, „Schizophrenia Bulletin”, 32 Suppl 1, 2006, S24–31, DOI: 10.1093/schbul/sbl014, ISSN0586-7614, PMID: 16885206, PMCID: PMC2632539.
Michael F.M.F.GreenMichael F.M.F., Cognitive impairment and functional outcome in schizophrenia and bipolar disorder, „The Journal of Clinical Psychiatry”, 67 Suppl 9, 2006, 3–8; discussion 36–42, ISSN0160-6689, PMID: 16965182.
H.M.H.M.JonesH.M.H.M., L.S.L.S.PilowskyL.S.L.S., Dopamine and antipsychotic drug action revisited, „The British Journal of Psychiatry: The Journal of Mental Science”, 181, 2002, s. 271–275, ISSN0007-1250, PMID: 12356650.
ChristineCh.KonradiChristineCh., StephanS.HeckersStephanS., Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment, „Pharmacology & Therapeutics”, 97 (2), 2003, s. 153–179, ISSN0163-7258, PMID: 12559388, PMCID: PMC4203361.
A.C.A.C.LahtiA.C.A.C. i inni, Effects of ketamine in normal and schizophrenic volunteers, „Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology”, 25 (4), 2001, s. 455–467, DOI: 10.1016/S0893-133X(01)00243-3, ISSN0893-133X, PMID: 11557159.
Joseph T.J.T.CoyleJoseph T.J.T., GuochuanG.TsaiGuochuanG., DonaldD.GoffDonaldD., Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia, „Annals of the New York Academy of Sciences”, 1003, 2003, s. 318–327, ISSN0077-8923, PMID: 14684455.
Harri J.H.J.TuominenHarri J.H.J., JariJ.TiihonenJariJ., KristianK.WahlbeckKristianK., Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis, „Schizophrenia Research”, 72 (2-3), 2005, s. 225–234, DOI: 10.1016/j.schres.2004.05.005, ISSN0920-9964, PMID: 15560967.1 stycznia
E.C.E.C.JohnstoneE.C.E.C. i inni, Cerebral ventricular size and cognitive impairment in chronic schizophrenia, „The Lancet”, 2 (7992), London, England 1976, s. 924–926, ISSN0140-6736, PMID: 62160.
Laura A.L.A.FlashmanLaura A.L.A., Michael F.M.F.GreenMichael F.M.F., Review of cognition and brain structure in schizophrenia: profiles, longitudinal course, and effects of treatment, „The Psychiatric Clinics of North America”, 27 (1), 2004, s. 1–18, vii, DOI: 10.1016/S0193-953X(03)00105-9, ISSN0193-953X, PMID: 15062627.
Amanda L.A.L.JonesAmanda L.A.L. i inni, Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?, „Immunology and Cell Biology”, 83 (1), 2005, s. 9–17, DOI: 10.1111/j.1440-1711.2005.01305.x, ISSN0818-9641, PMID: 15661036.
Rael D.R.D.StrousRael D.R.D., YehudaY.ShoenfeldYehudaY., Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited, „Journal of Autoimmunity”, 27 (2), 2006, s. 71–80, DOI: 10.1016/j.jaut.2006.07.006, ISSN0896-8411, PMID: 16997531.
R.R.DayR.R. i inni, Stressful life events preceding the acute onset of schizophrenia: a cross-national study from the World Health Organization, „Culture, Medicine and Psychiatry”, 11 (2), 1987, s. 123–205, ISSN0165-005X, PMID: 3595169.a?
CherylCh.CorcoranCherylCh. i inni, The stress cascade and schizophrenia: etiology and onset, „Schizophrenia Bulletin”, 29 (4), 2003, s. 671–692, ISSN0586-7614, PMID: 14989406.
Regina A.R.A.ShihRegina A.R.A., Pamela L.P.L.BelmontePamela L.P.L., Peter P.P.P.ZandiPeter P.P.P., A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders, „International Review of Psychiatry (Abingdon, England)”, 16 (4), 2004, s. 260–283, DOI: 10.1080/09540260400014401, ISSN0954-0261, PMID: 16194760.
M.J.M.J.OwenM.J.M.J., N.N.CraddockN.N., M.C.M.C.O'DonovanM.C.M.C., Schizophrenia: genes at last?, „Trends in genetics: TIG”, 21 (9), 2005, s. 518–525, DOI: 10.1016/j.tig.2005.06.011, ISSN0168-9525, PMID: 16009449.
Michael C.M.C.O'DonovanMichael C.M.C., Nigel M.N.M.WilliamsNigel M.N.M., Michael J.M.J.OwenMichael J.M.J., Recent advances in the genetics of schizophrenia, „Human Molecular Genetics”, 12 Spec No 2, 2003, R125–133, DOI: 10.1093/hmg/ddg302, ISSN0964-6906, PMID: 12952866.
NickN.CraddockNickN., Michael C.M.C.O'DonovanMichael C.M.C., Michael J.M.J.OwenMichael J.M.J., Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology, „Schizophrenia Bulletin”, 32 (1), 2006, s. 9–16, DOI: 10.1093/schbul/sbj033, ISSN0586-7614, PMID: 16319375, PMCID: PMC2632175.
J.T.J.T.DalbyJ.T.J.T., D.D.MorganD.D., M.L.M.L.LeeM.L.M.L., Schizophrenia and mania in identical twin brothers, „The Journal of Nervous and Mental Disease”, 174 (5), 1986, s. 304–308, ISSN0022-3018, PMID: 3701318.
Jean-PaulJ.P.SeltenJean-PaulJ.P., ElizabethE.Cantor-GraaeElizabethE., René S.R.S.KahnRené S.R.S., Migration and schizophrenia, „Current Opinion in Psychiatry”, 20 (2), 2007, s. 111–115, DOI: 10.1097/YCO.0b013e328017f68e, ISSN0951-7367, PMID: 17278906.
Lindsay S.L.S.SchenkelLindsay S.L.S. i inni, Histories of childhood maltreatment in schizophrenia: relationships with premorbid functioning, symptomatology, and cognitive deficits, „Schizophrenia Research”, 76 (2-3), 2005, s. 273–286, DOI: 10.1016/j.schres.2005.03.003, ISSN0920-9964, PMID: 15949659.
I.I.JanssenI.I. i inni, Childhood abuse as a risk factor for psychotic experiences, „Acta Psychiatrica Scandinavica”, 109 (1), 2004, s. 38–45, ISSN0001-690X, PMID: 14674957.
Richard P.R.P.BentallRichard P.R.P. i inni, Prospects for a cognitive-developmental account of psychotic experiences, „The British Journal of Clinical Psychology”, 46 (Pt 2), 2007, s. 155–173, DOI: 10.1348/014466506X123011, ISSN0144-6657, PMID: 17524210.
Kenneth L.K.L.SubotnikKenneth L.K.L. i inni, Are communication deviance and expressed emotion related to family history of psychiatric disorders in schizophrenia?, „Schizophrenia Bulletin”, 28 (4), 2002, s. 719–729, ISSN0586-7614, PMID: 12795501.
H.-L.H.L.WangH.-L.H.L. i inni, Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia, „Acta Psychiatrica Scandinavica”, 114 (1), 2006, s. 40–48, DOI: 10.1111/j.1600-0447.2006.00780.x, ISSN0001-690X, PMID: 16774660.
LynseyL.GreggLynseyL., ChristineCh.BarrowcloughChristineCh., GillianG.HaddockGillianG., Reasons for increased substance use in psychosis, „Clinical Psychology Review”, 27 (4), 2007, s. 494–510, DOI: 10.1016/j.cpr.2006.09.004, ISSN0272-7358, PMID: 17240501.
K.T.K.T.MueserK.T.K.T. i inni, Prevalence of substance abuse in schizophrenia: demographic and clinical correlates, „Schizophrenia Bulletin”, 16 (1), 1990, s. 31–56, ISSN0586-7614, PMID: 2333480.
LouiseL.ArseneaultLouiseL. i inni, Causal association between cannabis and psychosis: examination of the evidence, „The British Journal of Psychiatry: The Journal of Mental Science”, 184, 2004, s. 110–117, DOI: 10.1192/bjp.184.2.110, ISSN0007-1250, PMID: 14754822.
S.S.AndréassonS.S. i inni, Cannabis and schizophrenia. A longitudinal study of Swedish conscripts, „The Lancet”, 2 (8574), London, England 1987, s. 1483–1486, ISSN0140-6736, PMID: 2892048.
RalphR.LewisRalphR., Should cognitive deficit be a diagnostic criterion for schizophrenia?, „Journal of psychiatry & neuroscience: JPN”, 29 (2), 2004, s. 102–113, ISSN1180-4882, PMID: 15069464.
MartinM.BrüneMartinM. i inni, Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best?, „Schizophrenia Research”, 92 (1-3), 2007, s. 151–159, DOI: 10.1016/j.schres.2007.01.006, ISSN0920-9964, PMID: 17346931.
Margriet M.M.M.SitskoornMargriet M.M.M. i inni, Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis, „Schizophrenia Research”, 71 (2-3), 2004, s. 285–295, DOI: 10.1016/j.schres.2004.03.007, ISSN0920-9964, PMID: 15474899.
Matthew M.M.M.KurtzMatthew M.M.M., Neurocognitive impairment across the lifespan in schizophrenia: an update, „Schizophrenia Research”, 74 (1), 2005, s. 15–26, DOI: 10.1016/j.schres.2004.07.005, ISSN0920-9964, PMID: 15694750.
Alex S.A.S.CohenAlex S.A.S., Nancy M.N.M.DochertyNancy M.N.M., Affective reactivity of speech and emotional experience in patients with schizophrenia, „Schizophrenia Research”, 69 (1), 2004, s. 7–14, DOI: 10.1016/S0920-9964(03)00069-0, ISSN0920-9964, PMID: 15145465.
William P.W.P.HoranWilliam P.W.P., Jack J.J.J.BlanchardJack J.J.J., Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping, „Schizophrenia Research”, 60 (2-3), 2003, s. 271–283, ISSN0920-9964, PMID: 12591589.
ChristineCh.BarrowcloughChristineCh. i inni, Self-esteem in schizophrenia: relationships between self-evaluation, family attitudes, and symptomatology, „Journal of Abnormal Psychology”, 112 (1), 2003, s. 92–99, DOI: 10.1037/0021-843X.112.1.92, ISSN0021-843X, PMID: 12653417.
M.M.BirchwoodM.M. i inni, The power and omnipotence of voices: subordination and entrapment by voices and significant others, „Psychological Medicine”, 30 (2), 2000, s. 337–344, ISSN0033-2917, PMID: 10824654.
BenB.SmithBenB. i inni, Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations, „Schizophrenia Research”, 86 (1-3), 2006, s. 181–188, DOI: 10.1016/j.schres.2006.06.018, ISSN0920-9964, PMID: 16857346.
VaughanV.BellVaughanV., Peter W.P.W.HalliganPeter W.P.W., Hadyn D.H.D.EllisHadyn D.H.D., Explaining delusions: a cognitive perspective, „Trends in Cognitive Sciences”, 10 (5), 2006, s. 219–226, DOI: 10.1016/j.tics.2006.03.004, ISSN1364-6613, PMID: 16600666.
ElizabethE.KuipersElizabethE. i inni, Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms, „Schizophrenia Bulletin”, 32 Suppl 1, 2006, S24–31, DOI: 10.1093/schbul/sbl014, ISSN0586-7614, PMID: 16885206, PMCID: PMC2632539.
Michael F.M.F.GreenMichael F.M.F., Cognitive impairment and functional outcome in schizophrenia and bipolar disorder, „The Journal of Clinical Psychiatry”, 67 Suppl 9, 2006, 3–8; discussion 36–42, ISSN0160-6689, PMID: 16965182.
H.M.H.M.JonesH.M.H.M., L.S.L.S.PilowskyL.S.L.S., Dopamine and antipsychotic drug action revisited, „The British Journal of Psychiatry: The Journal of Mental Science”, 181, 2002, s. 271–275, ISSN0007-1250, PMID: 12356650.
ChristineCh.KonradiChristineCh., StephanS.HeckersStephanS., Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment, „Pharmacology & Therapeutics”, 97 (2), 2003, s. 153–179, ISSN0163-7258, PMID: 12559388, PMCID: PMC4203361.
A.C.A.C.LahtiA.C.A.C. i inni, Effects of ketamine in normal and schizophrenic volunteers, „Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology”, 25 (4), 2001, s. 455–467, DOI: 10.1016/S0893-133X(01)00243-3, ISSN0893-133X, PMID: 11557159.
Joseph T.J.T.CoyleJoseph T.J.T., GuochuanG.TsaiGuochuanG., DonaldD.GoffDonaldD., Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia, „Annals of the New York Academy of Sciences”, 1003, 2003, s. 318–327, ISSN0077-8923, PMID: 14684455.
Harri J.H.J.TuominenHarri J.H.J., JariJ.TiihonenJariJ., KristianK.WahlbeckKristianK., Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis, „Schizophrenia Research”, 72 (2-3), 2005, s. 225–234, DOI: 10.1016/j.schres.2004.05.005, ISSN0920-9964, PMID: 15560967.1 stycznia
E.C.E.C.JohnstoneE.C.E.C. i inni, Cerebral ventricular size and cognitive impairment in chronic schizophrenia, „The Lancet”, 2 (7992), London, England 1976, s. 924–926, ISSN0140-6736, PMID: 62160.
Laura A.L.A.FlashmanLaura A.L.A., Michael F.M.F.GreenMichael F.M.F., Review of cognition and brain structure in schizophrenia: profiles, longitudinal course, and effects of treatment, „The Psychiatric Clinics of North America”, 27 (1), 2004, s. 1–18, vii, DOI: 10.1016/S0193-953X(03)00105-9, ISSN0193-953X, PMID: 15062627.
Amanda L.A.L.JonesAmanda L.A.L. i inni, Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?, „Immunology and Cell Biology”, 83 (1), 2005, s. 9–17, DOI: 10.1111/j.1440-1711.2005.01305.x, ISSN0818-9641, PMID: 15661036.
Rael D.R.D.StrousRael D.R.D., YehudaY.ShoenfeldYehudaY., Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited, „Journal of Autoimmunity”, 27 (2), 2006, s. 71–80, DOI: 10.1016/j.jaut.2006.07.006, ISSN0896-8411, PMID: 16997531.